Lincoln Pharmaceuticals Limited (LINCOLN) — Board Meeting | 13 August 2026

13 August 2026 · NSE 🟡 Notable ✨ Positive

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved Q1 FY27 consolidated financial results and recommended 18% dividend

🔄 What Changed

Net profit up 30.90% YoY to Rs. 36.23 crore; revenue up 19.02% YoY to Rs. 201.55 crore; EBITDA up 32.29% YoY to Rs. 51.70 crore

🔮 What's Next

Targeting Rs. 1,000 crore revenue in three years with 15-18% annual growth; expanding exports to 90 countries

💡 Investor Takeaway

Strong quarterly growth and dividend recommendation signal healthy momentum and shareholder-friendly policy

Lincoln Pharmaceuticals announced its Q1 FY27 consolidated financial results on August 13, 2026, showing a 30.90% year-on-year increase in net profit to Rs. 36.23 crore, driven by 19.02% revenue growth to Rs. 201.55 crore and 32.29% EBITDA growth to Rs. 51.70 crore. The board approved the unaudited results and recommended a 18% dividend for FY25-26. The company highlighted its net-debt free status, Crisil rating reaffirmation, and plans to expand exports to 90 countries while targeting Rs. 1,000 crore revenue in three years.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LINCOLN ✨ Ask AI About This

About Lincoln Pharmaceuticals Limited (LINCOLN)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,174.34 CrP/E: 12.2ROE: 12.7%ROCE: 16.9%Div Yield: 0.31%

View full LINCOLN stock details →

📡 Get AI alerts when LINCOLN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LINCOLN — Free

💡 Ask AI about this filing

"What is Lincoln's target debt ratio by FY27?""How will export expansion to 90 countries impact margins?""What is the timeline for new product launches in cardiac segment?"

Ask AI Free →

📊 More LINCOLN filings

🔴 Announcement — 24 September 2026Lincoln Pharmaceuticals announced the appointment of Pradeep Kumar Yadav as Senior General Manager-Q...
🔴 Announcement — 24 September 2026Lincoln Pharmaceuticals announced the resignation of Mr. Manoj Rai, Sr. General Manager- QA (Head QA...
Announcement — 23 September 2026Lincoln Pharmaceuticals has announced that its trading window will close on October 1, 2026, and rem...
🔴 Annual Report — 5 September 2026Lincoln Pharmaceuticals reported FY2025-26 revenue of **₹671.03 crores**, EBITDA of **[amount contex...
🟡 Board Meeting — 5 September 2026Lincoln Pharmaceuticals announced its 32nd Annual General Meeting will be held on September 30, 2026...

See all LINCOLN filings →

🔥 Also filed on 13 August 2026

EIFFLEuro India Fresh Foods LimitedCorporate Action APOLLOHOSPApollo Hospitals Enterprise LimitedFinancial Results EIDPARRYEID Parry India LimitedFinancial Results TAJGVKTaj GVK Hotels & Resorts LimitedCorporate Action SIGMAADVSIGMA ADVANCED SYSTEMS LIMITEDFinancial Results INDIQUBEIndiqube Spaces LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LINCOLN files new disclosures

Track LINCOLN filings, board meetings, and corporate actions. Free email alerts at 5 PM.